𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia Resistant to Tyrosine Kinase Inhibitors

✍ Scribed by Richard Champlin; Elias Jabbour; Partow Kebriaei; Paolo Anderlini; Borje Andersson; Marcos de Lima

Book ID
119218730
Publisher
Elsevier
Year
2011
Tongue
English
Weight
270 KB
Volume
11
Category
Article
ISSN
2152-2650

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novel tyrosine kinase inhibitor therapy
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia : No evidence for increased transplant-related toxicity
✍ Elias Jabbour; Jorge Cortes; Hagop Kantarjian; Sergio Giralt; Borje S. Andersson πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML) are increasingly likely to have received a novel tyrosine kinase inhibitor (NTKI) after failing imatinib mesylate. It is unknown whether the use of these NTKI